1. Show article details.

    BRIEF-Emergex Vaccines Announces Successful Coating Of Its COVID-19 Vaccine Onto Zosano Pharma's Micro-Needle Patch

    Reuters – 7:16 AM ET 05/17/2022

    Zosano Pharma Corp (ZSAN): * EMERGEX VACCINES ANNOUNCES SUCCESSFUL COATING OF ITS NOVEL CD8+ T CELL ADAPTIVE COVID-19 VACCINE ONTO ZOSANO PHARMA'S MICRO-NEEDLE PATCH. * EMERGEX - CO, ZOSANO HAVE SHOWED CO'S COVID-19 VACCINE IS STABLE ON PATCHES OVER A WIDE TEMP RANGE FOR UP TO 6 MONTHS AT 40C/75% RELATIVE HUMIDITY Source text for Eikon: Further company coverage:

  2. Show article details.

    12 Health Care Stocks Moving In Friday's After-Market Session

    Benzinga – 5:33 PM ET 05/13/2022

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

  3. Show article details.

    Zosano Pharma: Q1 Earnings Insights

    Benzinga – 5:26 PM ET 05/13/2022

    Zosano Pharma reported its Q1 earnings results on Friday, May 13, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Zosano Pharma reported in-line EPS of $-1.75 versus an estimate of $-1.75. Revenue was down $126.00 thousand from the same period last year. Last quarter the company missed on EPS by $0.7 which was followed by a 9.16% drop in the share price the next day.

  4. Show article details.

    BRIEF-Zosano Pharma Says Board Approved Decreasing Size Of Board To Five Members

    Reuters – 4:16 PM ET 05/13/2022

    Zosano Pharma Corp (ZSAN): * Zosano Pharma Corp (ZSAN)- ON MAY 10 JOSEPH "JAY" P. HAGAN TENDERED HIS RESIGNATION AS DIRECTOR OF BOARD AND AS CHAIRPERSON OF THE AUDIT COMMITTEE OF BOARD. * Zosano Pharma Corp (ZSAN)- BOARD APPROVED DECREASING THE SIZE OF THE BOARD TO FIVE MEMBERS Further company coverage:

  5. Show article details.

    BRIEF-Zosano Pharma Q1 Loss Per Share $7.86

    Reuters – 4:09 PM ET 05/13/2022

    Zosano Pharma Corp (ZSAN): * ZOSANO PHARMA REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS. * Q1 LOSS PER SHARE $7.86. * WILL NEED SUBSTANTIAL ADDITIONAL FUNDING TO FUND ITS OPERATIONS. * WILL NOT BE ABLE TO CONTINUE AS A GOING CONCERN IF IT IS UNABLE TO RAISE ADDITIONAL FUNDS. * AS OF MAY 11, 2022, COMPANY HAD APPROXIMATELY $9.9 MILLION OF CASH AND CASH EQUIVALENTS.

  6. Show article details.

    Zosano Pharma Reports First Quarter 2022 Financial Results

    GlobeNewswire – 4:00 PM ET 05/13/2022

    Zosano Pharma Corporation , a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended March 31, 2022. Zosano reported a net loss for the first quarter of 2022 of $33.4 million, or $7.86 per share on a basic and diluted basis, compared with a net loss of $8.1 million, or $2.73 per share on a basic and diluted basis, for the same quarter in 2021.

  7. Show article details.

    Zosano Pharma's Return On Capital Employed Insights

    Benzinga – 9:49 AM ET 05/09/2022

    According to data from Benzinga Pro, during Q4, Zosano Pharma's reported sales totaled $87.00 thousand. Earnings data without context is not clear and can be difficult to base trading decisions on. It is important to keep in mind that ROCE evaluates past performance and is not used as a predictive tool.

  8. Show article details.

    81 Biggest Movers From Yesterday

    Benzinga – 4:31 AM ET 05/05/2022

    81 Biggest Movers From Yesterday

  9. Show article details.

    66 Biggest Movers From Yesterday

    Benzinga – 6:08 AM ET 05/03/2022

    66 Biggest Movers From Yesterday

  10. Show article details.

    Mid-Day Market Update: Dow Drops Over 100 Points; Hilltop Holdings Shares Spike Higher

    Benzinga – 12:17 PM ET 05/02/2022

    U.S. stocks traded mostly lower midway through trading, with the Dow Jones dropping more than 100 points on Monday. The Dow traded down 0.42% to 32,837.09 while the NASDAQ rose 0.03% to 12,338.47. The S&P also fell, dropping, 0.39% to 4,115.72. Also check this: Executives Buy Around $1.6M Of 4 Penny Stocks Leading and Lagging Sectors Communication services shares climbed 1.9% on Monday.

  11. Show article details.

    31 Stocks Moving In Monday's Mid-Day Session

    Benzinga – 12:17 PM ET 05/02/2022

    31 Stocks Moving In Monday's Mid-Day Session

  12. Show article details.

    Zosano Pharma Announces Additional Workforce Layoff

    Benzinga – 9:13 AM ET 05/02/2022

    Zosano Pharma Announces Additional Workforce Layoff

  13. Show article details.

    12 Health Care Stocks Moving In Monday's Pre-Market Session

    Benzinga – 8:21 AM ET 05/02/2022

      This article was generated by Benzinga's automated content engine and reviewed by an editor.

  14. Show article details.

    20 Stocks Moving in Monday's Pre-Market Session

    Benzinga – 7:52 AM ET 05/02/2022

    Don't forget to check out our premarket coverage here .

  15. Show article details.

    BRIEF-Zosano Pharma Recently Implemented An Additional Workforce Reduction

    Reuters – 4:04 PM ET 04/29/2022

    Zosano Pharma Corp (ZSAN): * ZOSANO PHARMA PROVIDES CORPORATE UPDATE. * Zosano Pharma Corp (ZSAN) - RECENTLY IMPLEMENTED AN ADDITIONAL WORKFORCE REDUCTION IMPACTING APPROXIMATELY 40% OF ITS REMAINING EMPLOYEES. * Zosano Pharma Corp (ZSAN) - IN ORDER TO PRESERVE ITS CAPITAL AND CASH RESOURCES, ZOSANO HAS SUSPENDED ITS M207 PROGRAM.

  16. Show article details.

    Zosano Pharma Provides Corporate Update

    GlobeNewswire – 4:00 PM ET 04/29/2022

    Zosano Pharma Corporation , a clinical-stage biopharmaceutical company, today provided a corporate update. On April 14, 2022, the Food and Drug Administration granted Zosano a twelve-month extension to April 20, 2023 to resubmit its M207 New Drug Application.

  17. Show article details.

    26 Stocks Moving in Monday's Pre-Market Session

    Benzinga – 6:13 AM ET 04/25/2022

    Don't forget to check out our premarket coverage here .

  18. Show article details.

    12 Health Care Stocks Moving In Tuesday's After-Market Session

    Benzinga – 5:41 PM ET 04/19/2022

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

  19. Show article details.

    12 Health Care Stocks Moving In Tuesday's Intraday Session

    Benzinga – 2:05 PM ET 04/12/2022

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

  20. Show article details.

    BRIEF-Zosano Pharma Announces Reverse Stock Split Effective Today

    Reuters – 10:46 AM ET 04/11/2022

    Zosano Pharma Corp (ZSAN): * ZOSANO PHARMA ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE TODAY. * Zosano Pharma Corp (ZSAN) - BOARD OF DIRECTORS HAS APPROVED A 1-FOR-35 REVERSE STOCK SPLIT OF COMPANY'S COMMON STOCK. * Zosano Pharma Corp (ZSAN) - REVERSE STOCK SPLIT WILL BECOME EFFECTIVE TODAY, APRIL 11, 2022.

Page:

Today's and Upcoming Events

No events in the next 90 days

Past Events (last 90 days)

  • May
    13

    ZSAN announced Q1 earnings.

Data provided by Thomson Reuters © 2022

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.